TABLE 7.

Recipient and Donor Characteristics at Re-LT for Disease REC in Patients With PSC

	Re-LT for REC (n = 178)	Other Re-LT (n = 451)	P Value*	Primary LT (n = 5080)	P Value†
Age at LT, years	47 (38–56)	45 (36–55)	0.08	48 (38–57)	0.44
Male sex	134 (75.3)	324 (71.8)	0.38	3453 (68.0)	0.04
Race/ethnicity			0.43		0.60
White	140 (78.7)	378 (83.8)		4168 (82.0)
Black	28 (15.7)	54 (12.0)		629 (12.4)
Hispanic	8 (4.5)	14 (3.1)		187 (3.7)
Asian	1 (0.6)	4 (0.9)		62 (1.2)
Other	1 (0.6)	1 (0.2)		33 (0.6)
Location			<0.001		<0.001
In ICU	21 (11.8)	162 (35.9)		377 (7.4)
Hospitalized	44 (24.7)	133 (29.5)		804 (15.8)
Ambulatory	113 (63.5)	156 (34.6)		3897 (76.7)
Mechanical ventilation	10 (5.6)	92 (20.4)	<0.001	100 (2.0)	0.004
MELD score‡	25 (20–34)	24 (17–32)	0.12	19 (14–26)	<0.001
Total bilirubin	13.3 (5.4–26.5)	9.4 (3.1–22.6)	0.01	6.4 (2.7–15.0)	<0.001
Creatinine	1.4 (0.9–2.5)	1.3 (0.9–2.1)	0.11	0.9 (0.7–1.2)	<0.001
Albumin	2.8 (2.3–3.4)	2.8 (2.4–3.3)	0.49	3.0 (2.5–3.5)	0.08
Living donor	4 (2.2)	4 (0.9)	0.23	551 (10.8)	<0.001
DCD donor	2 (1.1)	4 (0.9)	0.68	120 (2.4)	0.44
Donor age ≥ 60 years	14 (7.9)	45 (10.0)	0.41	620 (12.2)	0.08
Split graft	4 (2.2)	8 (1.8)	0.75	621 (12.2)	<0.001

NOTE: Data are given as n (%) or median (IQR).

^*Comparison between re-LT for disease REC versus other indications.

^†Comparison between re-LT for disease REC versus primary LT.

^‡Available for transplants performed after February 27, 2002 (n = 164/178, 278/451, and 3175/5080).